 | | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 But Plavix therapy did not reduce the incidence of cases in which the fistula could not be used for dialysis, which was 61.8 percent in those getting the drug and 59.5 percent in those getting a placebo.
The rate of fistula failure was about 50 percent higher than anticipated, Dember said, and that might have an effect on future practice.
"There has been an increased emphasis on trying to create fistulas in as many patients as possible," she said. "So, the criteria have changed. We need to develop better methods for selecting suitable candidates for fistula creation."
Text Continues Below
The trial also indicated the direction that that research should take, Dember said.
"Our future efforts should be directed at understanding the basic mechanisms of fistula maturation," she said. "If we better understand those mechanisms, we should be able to identify maturity-enhancing interventions."
More information
The basics of kidney dialysis are explained by the U.S. National Library of Medicine.
Page: << Prev | 1 | 2
|
.gif)
